A 5 mol/L increase in Hcy raises the chance of early death by 33.6%
Open Access funding enabled and organized by Projekt DEAL
What new research on GLP-1s and migraines found In a 12-week study published in Headache: The Journal of Head and Face Pain , researchers tracked adults living with both obesity and chronic migraines who added the GLP-1 medication liraglutide (brand name Victoza) to their usual migraine treatment
Obesity and overweight, which are common in patients with DM2, are a factors that favor the development/progression of CKD through both direct and indirect effects.69 Although the precise mechanisms the association between obesity and CKD are not totally defined it has been proposed that hypertension, glomerular hyperfiltration, hyperglycemia, lipid toxicity, inflammation or the role of adipose tissue and its adipokines are involved.70 Weight reduction by bariatric surgery, pharmacological treatment or dietary measures are associated with a nephroprotective effect,7173 so that weight reduction is a fundamental objective in the nephroprotection of patients with DKD
These substances, known as volatile organic compounds or VOCs, produce the musty odor of mold